Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds
- 28 February 1990
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 36 (2), 207-211
- https://doi.org/10.1016/0090-8258(90)90174-j
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Cisplatin/carboplatin cross-resistance in ovarian cancerBritish Journal of Cancer, 1989
- Ovarian trials at the Royal MarsdenCancer Treatment Reviews, 1985
- Recurrent ovarian carcinoma: Retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agentGynecologic Oncology, 1985
- Combined cyclophosphamide, adriamycin and cis-platinum in advanced ovarian cancer resistant to chlorambucil and cis-platinumGynecologic Oncology, 1985
- Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancerGynecologic Oncology, 1985
- Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdensCancer, 1983
- USE OF HIGH DOSE CIS-DICHLORODIAMMINE PLATINUM (II) (NSC-119875)+ FOLLOWING FAILURE ON PREVIOUS CHEMOTHERAPY FOR ADVANCED CARCINOMA OF THE OVARYBJOG: An International Journal of Obstetrics and Gynaecology, 1981
- Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycinCancer, 1981